Skip to main content
Equibles

Legal & General Group Plc

Position in IMVT — Immunovant, Inc.

CIK 764068 London, X0
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,609,134
+$759,649 QoQ
Shares Held
67,717
-9.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. IMVT ranks #72 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in IMVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,609,134 67,717
2026-03-31 $1,849,485 74,456
2025-12-31 $2,356,788 92,714
2025-09-30 $1,403,679 87,077
2025-06-30 $1,236,736 77,296
2025-03-31 $1,235,366 72,286
2024-12-31 $1,461,181 58,990
2024-09-30 $1,579,281 55,394
2024-06-30 $1,425,176 53,984
2024-03-31 $1,721,023 53,266
2023-12-31 $2,253,448 53,488
2023-09-30 $2,276,833 59,308
2023-06-30 $963,257 50,778
2023-03-31 $233,673 15,066
2022-12-31 $252,031 14,199
2022-09-30 $79,230 14,199
2022-06-30 $113,329 29,059
2022-03-31 $164,385 29,834
2021-12-31 $252,984 29,693
2021-09-30 $243,805 28,056
2021-06-30 $221,811 20,985
2021-03-31 $350,457 21,849
2020-12-31 $256,861 5,561
2020-09-30 $205,263 5,833
2020-06-30 $101,003 4,148